Trials / Completed
CompletedNCT04359706
Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With SARS-CoV2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational pilot single-center study aiming to determine the microbiota of critically ill patients infected with SARS-CoV-2. COVID-19 patients will be compared to historical critically ill controls with no SARS-CoV-2 infection.
Detailed description
Observational pilot single-center study aiming to determine the microbiota of critically ill patients infected with SARS-CoV-2. COVID-19 patients will be compared to historical critically ill controls with no SARS-CoV-2 infection. Respiratory and fecal microbiota (microbial and fungal) will be determined in COVID-19 patients on bronchoalveolar lavage and rectal swab. Inflammatory biomarkers will also be measured in COVID-19 patients. Characteristics of study patients will be collected at ICU admission and during ICU stay.
Conditions
Timeline
- Start date
- 2020-05-08
- Primary completion
- 2020-10-23
- Completion
- 2020-10-23
- First posted
- 2020-04-24
- Last updated
- 2022-10-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04359706. Inclusion in this directory is not an endorsement.